Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
Abstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss wi...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-021-02363-z |
_version_ | 1817997201433952256 |
---|---|
author | Yong Hu Min-Cong Wang Tao Wang Yue Meng Xiao-Min Chao Hui-Feng Zhu Cheng-Guo Li Cheng-Long Pan He-Bei He |
author_facet | Yong Hu Min-Cong Wang Tao Wang Yue Meng Xiao-Min Chao Hui-Feng Zhu Cheng-Guo Li Cheng-Long Pan He-Bei He |
author_sort | Yong Hu |
collection | DOAJ |
description | Abstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). Methods This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. Results Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. Conclusion SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH. |
first_indexed | 2024-04-14T02:34:49Z |
format | Article |
id | doaj.art-c59f8577f443442b9b1edf27012276e8 |
institution | Directory Open Access Journal |
issn | 1749-799X |
language | English |
last_indexed | 2024-04-14T02:34:49Z |
publishDate | 2021-03-01 |
publisher | BMC |
record_format | Article |
series | Journal of Orthopaedic Surgery and Research |
spelling | doaj.art-c59f8577f443442b9b1edf27012276e82022-12-22T02:17:34ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-03-011611910.1186/s13018-021-02363-zLess blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplastyYong Hu0Min-Cong Wang1Tao Wang2Yue Meng3Xiao-Min Chao4Hui-Feng Zhu5Cheng-Guo Li6Cheng-Long Pan7He-Bei He8Present Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Orthopaedic Surgery, The Third Affiliated Hospital of GuangZhou Medical CollegePresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityAbstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). Methods This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. Results Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. Conclusion SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH.https://doi.org/10.1186/s13018-021-02363-zTotal hip arthroplastySupercapsular percutaneously assistedMinimally invasiveBlood lossTransfusion |
spellingShingle | Yong Hu Min-Cong Wang Tao Wang Yue Meng Xiao-Min Chao Hui-Feng Zhu Cheng-Guo Li Cheng-Long Pan He-Bei He Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty Journal of Orthopaedic Surgery and Research Total hip arthroplasty Supercapsular percutaneously assisted Minimally invasive Blood loss Transfusion |
title | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_full | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_fullStr | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_full_unstemmed | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_short | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_sort | less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
topic | Total hip arthroplasty Supercapsular percutaneously assisted Minimally invasive Blood loss Transfusion |
url | https://doi.org/10.1186/s13018-021-02363-z |
work_keys_str_mv | AT yonghu lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT mincongwang lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT taowang lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT yuemeng lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT xiaominchao lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT huifengzhu lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT chengguoli lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT chenglongpan lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT hebeihe lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty |